Pseudonymized Data in Clinical Trials: Why EDPB’s Perspective Should Prevail Over ICO’s Guidance
February 11, 2025
Explore our featured blogs for insights, strategies, and updates on privacy, compliance, and data protection in the life sciences industry.
February 11, 2025
The European Data Protection Board (EDPB) Guidelines on Pseudonymization state: “Pseudonymised data, which could be attributed to a… Read More
February 7, 2025
The General Data Protection Regulation (GDPR) grants individuals a range of rights over their personal data, and sponsors… Read More
January 23, 2025
In September 2024, the Dutch Data Protection Authority (DPA) made headlines by announcing an unprecedented move to hold… Read More
December 9, 2024
In a significant development for data protection and privacy advocacy, noyb (None of Your Business), the European Center… Read More
December 2, 2024
Data Protection Impact Assessments (DPIAs) are essential tools for identifying and managing privacy risks, particularly when handling sensitive… Read More
November 25, 2024
The Health Research Authority (HRA) in the UK has released updated, approved language for the privacy sections of… Read More
Explore our library of AI-powered courses designed to build practical skills and support professional growth.
RDPrivacy is a trusted all-in-one privacy and compliance partner for pharmaceutical and life sciences companies. Our solutions help organizations manage clinical trial privacy, corporate compliance, and international data protection requirements in a more efficient, secure, and practical way.
Making data privacy simpler, more secure, and fully compliant.
© 2026 RD Privacy ALL RIGHTS RESERVED
© 2025 Research & Development Privacy Consultancy S.L. ALL RIGHTS RESERVED